Recombinant human erythropoietin prevents the death of mice during cerebral malaria

Journal of Infectious Diseases

Volumn 193, Issue 7, 2006, Pages 987-995

  Kaiser, Karins ^a   Texier, Anthony ^a   Ferrandiz, Josette ^a   Buguet, Alain ^a   Meiller, Anne ^a   Latour, Christine ^a   Peyron, François ^a   Cespuglio, Raymond ^a   Picot, Stéphane ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN HEMORRHAGE; BRAIN MALARIA; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE OVEREXPRESSION; MALARIA; MOUSE; NEUROPROTECTION; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SEIZURE; SURVIVAL;

EID: 33645369420     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/500844     Document Type: Article

References (35)

1. Mackintosh CL, Beeson JG, Marsch K. Clinical features and pathogenesis of severe malaria. Trends Parasitol 2004; 20:597-603.
2. Maitland K, Marsch K. Pathophysiology of severe malaria in children. Acta Trop 2004; 90:131-40.
3. Newton CR, Hien TT, White N. Cerebral malaria. J Neurol Neurosurg Psychiatry 2000; 69:433-41.
4. Patankar TF, Karnad DR, Shetty PG, Desai AP, Prasad SR. Adult cerebral malaria: prognostic importance of imaging findings and correlation with postmortem findings. Radiology 2002; 224:811-6.
5. Wassmer SC, Combes V, Grau GE. Pathophysiology of cerebral malaria: role of host cells in the modulation of cytoadhesion. Ann NY Acad Sci 2003; 992:30-8.
6. Combes V, Rosenkranz AR, Redard M, et al. Pathogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment. Am J Pathol 2004; 164:781-6.
7. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004; 11(Suppl 1):S37-44.
8. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005; 293:90-5.
9. Banks WA, Jumbe NL, Farrell CL, Niehoff ML, Heatherington AC. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. Eur J Pharmacol 2004; 505:93-101.
10. Zhang J, Li Y, Cui Y, et al. Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res 2005; 1034:34-9.
11. Mittelman M, Neumann D, Peled A, Kanter P, Haran-Ghera N. Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models. Proc Nad Acad Sci USA 2001; 98:5181-6.
12. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29:2002-7.
13. Burlet S, Cespuglio R. Voltammetric detection of nitric oxide (NO) in the rat brain: its variations throughout the sleep-wake cycle. Neurosci Lett 1997; 226:131-5.
14. Buguet A, Vincendeau P, Bouteille B, Burlet S, Cespuglio R. Nitric oxide in murine malaria: divergent roles in blood and brain suggested by voltametric measures. Trans R Soc Trop Med Hyg 1999; 93:663-4.
15. Chang KH, Tam M, Stevenson MM. Modulation of the course and outcome of blood-stage malaria by erythropoietin-induced reticulocytosis. J Infect Dis 2004; 189:735-43.
16. Ludwig H. rHuEPO and treatment outcomes: the preclinical experience. Oncologist 2004; 9:48-54.
17. Sattler MB, Merkler D, Maier K, et al. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 2004; 11(Suppl 2):S181-92.
18. Li F, Chong ZZ, Maiese K. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. Neurosignals 2004; 13:265-89.
19. Ohno T, Kobayashi F, Nishimura K. Fas has a role in cerebral malaria, but not in proliferation or exclusion of the murine parasite in mice. Immunogenetics 2005; 57:293-6.
20. Coleman T, Brines M. Science review: recombinant human erythropoietin in critical illness: a role beyond anemia? Crit Care 2004; 8: 337-41.
21. Chang KH, Stevenson MM. Comparison of murine Epo ELISA and Epo bioassays in detecting serum Epo levels during anemia associated with malaria infection. J Immunol Methods 2002; 262:129-36.
22. Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320:1586-91.
23. Grau GE, de Kossodo S. Cerebral malaria: mediators, mechanical obstruction or more? Parasitol Today 1994; 10:408-9.
24. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003; 24:491-9.
25. Grau GE, Heremans H, Piguet PF, et al. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci USA 1989; 86:5572-4.
26. Van Hensbroek MB, Palmer A, Onyiorah E, et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 1996; 174:1091-7.
27. Agnello D, Bigini P, Villa P, et al. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 2002; 952:128-34.
28. Villa P, Bigini P, Mennini T, et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003; 198:971-95.
29. Martinez-Estrada OM, Rodriguez-Millan E, Gonzalez-DeVicente E, Reina M, Vilaro S, Fabre M. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 2003; 18: 2538-44.
30. Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 2002; 106:2973-9.
31. Clark IA, Alleva LM, Mills AC, Cowden WB. Pathogenesis of malaria and clinically similar conditions. Clin Microbiol Rev 2004; 17:509-39.
32. Huang PL. Nitric oxide and cerebral ischemic preconditioning. Cell Calcium 2004; 36:323-9.
33. Kara MR, Agrawal N, Kim SF, et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siahl binding. Nat Cell Biol 2005; 7:665-74.
34. Zhou P, Qian L, Iadecola C. Nitric oxide inhibits caspase activation and apoptotic morphology but does not rescue neuronal death. J Cereb Blood Flow Metab 2005; 25:348-57.
35. Chong ZZ, Kang JQ, Maiese K. Erythropoietin: cytoprotection in vascular and neuronal cells. Curr Drug Targets Cardiovasc Haematol Disord 2003; 3:141-54.